Cardiac biomarkers in women with high-risk pregnancies: short-term outcomes from the Heidelberg Cardio-Obstetrics Registry

Pregnancy leads to profound physiological changes within the cardiovascular system. However, in women with pre-existing or pregnancy-associated cardiovascular disease (CVD) these adaptations may be insufficient and lead to maternal or fetal complications. The prognostic value of cardiac biomarkers s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Siry, Deborah (Autor) , Haney, Ailís Ceara (Autor) , Ehlermann, Philipp (Autor) , Frey, Norbert (Autor) , Hörbrand, Isabel (Autor) , Beckendorf, Jan (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: 2026
Edición:[Early access]
In: Clinical research in cardiology
Year: 2026, Pages: 1-11
ISSN:1861-0692
DOI:10.1007/s00392-026-02920-8
Acceso en línea:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00392-026-02920-8
Enlace del recurso
Notas de Autor:Deborah Siry, Ailís Ceara Haney, Philipp Ehlermann, Norbert Frey, Isabel Amber-Rose Hörbrand, Jan Beckendorf
Descripción
Sumario:Pregnancy leads to profound physiological changes within the cardiovascular system. However, in women with pre-existing or pregnancy-associated cardiovascular disease (CVD) these adaptations may be insufficient and lead to maternal or fetal complications. The prognostic value of cardiac biomarkers such as N-terminal B-type natriuretic peptide (NTproBNP) and high-sensitivity cardiac troponin-T (hscTnT) in this population remains unclear.
Notas:Online veröffentlicht: 15. April 2026
Gesehen am 17.06.2026
Descripción Física:Online Resource
ISSN:1861-0692
DOI:10.1007/s00392-026-02920-8